187 related articles for article (PubMed ID: 29197096)
21. Utility of paired box gene 8 (PAX8) expression in fluid and fine-needle aspiration cytology: an immunohistochemical study of metastatic ovarian serous carcinoma.
McKnight R; Cohen C; Siddiqui MT
Cancer Cytopathol; 2010 Oct; 118(5):298-302. PubMed ID: 20572292
[TBL] [Abstract][Full Text] [Related]
22. [Molecular markers derived from ovarian cancer and its correlation with the types of oviductal epithelial lesions].
Yuan Y; Zhu W; Gong G; Jiang J; Wang Y; Wu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 May; 44(5):528-534. PubMed ID: 31303616
[TBL] [Abstract][Full Text] [Related]
23. Somatically Derived Yolk Sac Tumor of the Ovary in a Young Woman.
Hodgson A; Ghorab Z; Parra-Herran C
Int J Gynecol Pathol; 2021 May; 40(3):296-300. PubMed ID: 32209818
[TBL] [Abstract][Full Text] [Related]
24. Early form of ovarian cancer originating in inclusion cysts. A case report.
Aoki Y; Kawada N; Tanaka K
J Reprod Med; 2000 Feb; 45(2):159-61. PubMed ID: 10710752
[TBL] [Abstract][Full Text] [Related]
25. Apocrine metaplasia: a new type of müllerian metaplasia.
Allen C; Johnson S
J Clin Pathol; 1993 Jun; 46(6):569. PubMed ID: 8331185
[TBL] [Abstract][Full Text] [Related]
26. Precursor lesions of ovarian epithelial malignancy.
Feeley KM; Wells M
Histopathology; 2001 Feb; 38(2):87-95. PubMed ID: 11207821
[TBL] [Abstract][Full Text] [Related]
27. Macrophages in human fallopian tube and ovarian epithelial inclusion cysts.
Gaytán M; Morales C; Bellido C; Sánchez-Criado JE; Gaytán F
J Reprod Immunol; 2007 Feb; 73(1):66-73. PubMed ID: 17014913
[TBL] [Abstract][Full Text] [Related]
28. Contralateral ovary in unilateral ovarian carcinoma: a search for preneoplastic lesions.
Mittal KR; Zeleniuch-Jacquotte A; Cooper JL; Demopoulos RI
Int J Gynecol Pathol; 1993 Jan; 12(1):59-63. PubMed ID: 8418079
[TBL] [Abstract][Full Text] [Related]
29. Ovarian surface epithelium as a source of ovarian cancers: unwarranted speculation or evidence-based hypothesis?
Auersperg N
Gynecol Oncol; 2013 Jul; 130(1):246-51. PubMed ID: 23558054
[TBL] [Abstract][Full Text] [Related]
30. The stem-cell profile of ovarian surface epithelium is reproduced in the oviductal fimbriae, with increased stem-cell marker density in distal parts of the fimbriae.
Auersperg N
Int J Gynecol Pathol; 2013 Sep; 32(5):444-53. PubMed ID: 23896717
[TBL] [Abstract][Full Text] [Related]
31. Endosalpingiosis as it relates to tubal, ovarian and serous neoplastic tissues: an immunohistochemical study of tubal and Müllerian antigens.
Esselen KM; Ng SK; Hua Y; White M; Jimenez CA; Welch WR; Drapkin R; Berkowitz RS; Ng SW
Gynecol Oncol; 2014 Feb; 132(2):316-21. PubMed ID: 24333360
[TBL] [Abstract][Full Text] [Related]
32. Pax8: a marker for carcinoma of Müllerian origin in serous effusions.
Tong GX; Devaraj K; Hamele-Bena D; Yu WM; Turk A; Chen X; Wright JD; Greenebaum E
Diagn Cytopathol; 2011 Aug; 39(8):567-74. PubMed ID: 20607683
[TBL] [Abstract][Full Text] [Related]
33. Irregularly shaped inclusion cysts display increased expression of Ki67, Fas, Fas ligand, and procaspase-3 but relatively little active caspase-3.
Slot KA; de Boer-Brouwer M; Voorendt M; Sie-Go DM; Ghahremani M; Dorrington JH; Teerds KJ
Int J Gynecol Cancer; 2006; 16(1):231-9. PubMed ID: 16445638
[TBL] [Abstract][Full Text] [Related]
34. Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium.
Kuhn E; Ayhan A; Shih IeM; Seidman JD; Kurman RJ
Eur J Cancer; 2013 Dec; 49(18):3839-49. PubMed ID: 24012099
[TBL] [Abstract][Full Text] [Related]
35. Different proportions of aneusomic cells in ovarian inclusion cysts associated with serous borderline tumours and serous high-grade carcinomas support different pathogenetic pathways.
Körner M; Burckhardt E; Mazzucchelli L
J Pathol; 2005 Sep; 207(1):20-6. PubMed ID: 16021676
[TBL] [Abstract][Full Text] [Related]
36. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
Manchanda R; Abdelraheim A; Johnson M; Rosenthal AN; Benjamin E; Brunell C; Burnell M; Side L; Gessler S; Saridogan E; Oram D; Jacobs I; Menon U
BJOG; 2011 Jun; 118(7):814-24. PubMed ID: 21392246
[TBL] [Abstract][Full Text] [Related]
37. Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.
de Cristofaro T; Di Palma T; Soriano AA; Monticelli A; Affinito O; Cocozza S; Zannini M
Oncotarget; 2016 Jul; 7(27):41929-41947. PubMed ID: 27259239
[TBL] [Abstract][Full Text] [Related]
38. Cells of origin of ovarian cancer: ovarian surface epithelium or fallopian tube?
Klotz DM; Wimberger P
Arch Gynecol Obstet; 2017 Dec; 296(6):1055-1062. PubMed ID: 28940023
[TBL] [Abstract][Full Text] [Related]
39. A comprehensive analysis of PAX8 expression in human epithelial tumors.
Laury AR; Perets R; Piao H; Krane JF; Barletta JA; French C; Chirieac LR; Lis R; Loda M; Hornick JL; Drapkin R; Hirsch MS
Am J Surg Pathol; 2011 Jun; 35(6):816-26. PubMed ID: 21552115
[TBL] [Abstract][Full Text] [Related]
40. Detailed morphology of human ovarian surface epithelium focusing on its metaplastic and neoplastic capability.
Okamura H; Katabuchi H
Ital J Anat Embryol; 2001; 106(2 Suppl 2):263-76. PubMed ID: 11732586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
